SERPINB2 and type 2 diabetes mellitus: Insulin resistance in T2D is associated with molecular pathways that establish a prothrombotic state, primarily through platelet and fibrin dysfunction and alterations in the expression of coagulation cascade factors, such as plasminogen activator inhibitor (PAI) and fibrinolysis inhibitor (FI) [35].